콘텐츠로 건너뛰기
Merck

D9652

Dialysis tubing cellulose membrane

avg. flat width 33 mm (1.3 in.)

동의어(들):

Cellulose Dialysis Tubing, Cellulose Membrane, Dialysis Membrane

조직 및 계약 가격을 보려면 로그인를 클릭합니다.

크기 선택

보기 변경

제품정보 (DICE 배송 시 비용 별도)

NACRES:
NB.22
UNSPSC Code:
41123100
기술 서비스
도움이 필요하신가요? 저희 숙련된 과학자 팀이 도와드리겠습니다.
도움 문의


avg. diam.

21 mm , when full

avg. flat width

33 mm (1.3 in.)

capacity

~110 mL/ft

General description

Typical molecular weight cut-off = 14,000.

Packaging

Supplied in rolls, dry

Preparation Note

Removal of glycerol included as a humectant can be accomplished by washing the tubing in running water for 3-4 hours. Removal of sulfur compounds can be accomplished by treating the tubing with a 0.3% (w/v) solution of sodium sulfide at 80°C for 1 minute. Wash with hot water (60°C) for 2 minutes, followed by acidification with a 0.2% (v/v) solution of sulfuric acid, then rinse with hot water to remove the acid. This tubing will retain most proteins of molecular weight 12,000 or greater.

Analysis Note

May contain glycerin and sulfur compounds in more than trace amounts.


Still not finding the right product?

Explore all of our products under


저장 등급

13 - Non Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable



가장 최신 버전 중 하나를 선택하세요:

시험 성적서(COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 문서 section.

도움이 필요하시면 연락하세요. 고객 지원 부서

이 제품을 이미 가지고 계십니까?

문서 라이브러리에서 최근에 구매한 제품에 대한 문서를 찾아보세요.

문서 라이브러리 방문


관련 콘텐츠

Dialysis Tubing


Fereshteh Abbasi et al.
International journal of biological macromolecules, 143, 492-500 (2019-12-13)
Developing the cheap but superior adsorbents is of importance for environmental applications. In this paper, the Taguchi experimental design was applied to establish the optimum condition for the removal of crystal violet (CV) dye using keratin nanoparticles obtained from human
Margarida Miranda et al.
International journal of pharmaceutics, 572, 118695-118695 (2019-09-20)
The EMA draft guideline on quality and equivalence of topical products and the FDA non-binding product specific guidances release has encouraged the establishment of a regulatory background for in vitro release testing (IVRT). Herein, a novel framework applicable to the
Ahmet Alper Öztürk et al.
Combinatorial chemistry & high throughput screening, 23(10), 1064-1079 (2020-03-27)
To prepare lamivudine (LAM)-loaded-nanoparticles (NPs) that can be used in lung cancer treatment. To change the antiviral indication of LAM to anticancer. The development of anticancer drugs is a difficult process. One approach to accelerate the availability of drugs is



국제 무역 품목 번호

SKUGTIN
D9652-100FT04061835270040